• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Lexatumumab Antibody – Human Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5818741

Lexatumumab (GHS-ETR 2) is a human excitatory monoclonal antibody targeting TRAIL receptor 2 that has anticancer activity and induces apoptosis in malignant mesothelioma. Lexatumumab can be used to study malignant pleural mesothelioma (MPM). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Lexatumumab, Monoclonal Antibody
Full Product Name
Lexatumumab
Product Synonym Names
ETR2-ST01; DR5 mAB; HGS-ETR 2
Clonality
Monoclonal
Host
Human
Species Reactivity
TRAIL receptor 2
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Molecular Weight
143.6 (kDa)
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
845816-02-6
In_vitro
Lexatumumab (10mg/kg, intravenous injection, twice a week) combined with Dacarbazine can increase the anti-tumor effect in mice [ 2 ].

Other Notes

Small volumes of anti-Lexatumumab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Lexatumumab purchase

MBS5818741 is an antibody targeting Lexatumumab. Reactive in TRAIL receptor 2. Host: Human.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000